Affiliation:
1. Smolensk State Medical University
2. A. N. Bakulev National Medical Research Center of Cardiovascular Surgery
3. Pavlov University
Abstract
Cardinal changes in approaches to the choice of antimicrobial therapy for severe infections have occurred in recent years. They are associated with the growth of antibiotic resistance of nosocomial pathogens and the lack of sufficiently effective «universal» schemes of empirical antibiotic therapy. Recent international and domestic recommendations focus on a «pathogen-specific» approach aimed at the treatment of infections caused by specific problematic resistant pathogens. The application of such «pathogen-specific» recommendations is not possible without the availability of appropriate quality microbiological data. The further evolution of diagnostic methods is directed creating test systems that allow detecting the main pathogens of infection and the most important antibiotic resistance genes, allowing to reduce the time from the moment of taking clinical material for microbiological examination to obtaining the result that affects the choice of antibiotic therapy regimen. The review contains practical recommendations on the choice of drugs for targeted antimicrobial therapy based on the clinical interpretation of the results obtained using the «hyperplex» panel BioFire BCID2 (Blood Culture Identification 2BCID2), taking into account the statements set out in the guidelines «Diagnosis and antimicrobial therapy for infections caused by polyresistant strains of microorganisms».
Publisher
FSBEI HE I.P. Pavlov SPbSMU MOH Russia
Subject
Anesthesiology and Pain Medicine,Critical Care and Intensive Care Medicine,Emergency Medicine
Reference21 articles.
1. Beloborodov V. B., Goloschapov O. V., Gusarov V. G. et al. Guidelines of the Association of Anesthesiologists-Intensivists, the Interregional Non-Governmental Organization Alliance of Clinical Chemotherapists and Microbiologists, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and NGO Russian Sepsis Forum “Diagnostics and antimicrobial therapy of the infections caused by multiresistant microorganisms” (update 2022). Messenger of anesthesiology and resuscitation, 2022, vol. 19, no. 2, pp. 84-114. (In Russ.) doi: 10.21292/2078-5658-2022-19-2-84-114.
2. BIOFIRE Blood Culture Identification 2 Panel (BCID2). (Epub.), Available: https://www.biomerieux-russia.com/клиническая-диагностика/продукт/панель-biofire®-bcid2 (Accessed 15. 03. 2023).
3. Both A., Berneking L., Berinson B. et al. Rapid identification of the vanA/vanB resistance determinant in Enterococcus sp. from blood cultures using the Cepheid Xpert vanA/vanB cartridge system // Diagn Microbiol Infect Dis. – 2020. – Vol. 96. – P. 114977. doi: 10.1016/j.diagmicrobio.2019.114977.
4. Camelena F. Performances et impact thérapeutique du BioFire Blood Culture Identification 2 (BCID2) Panel au cours du sepsis / 23es Journées Nationales d’Infectiologie. – Monpellier, France, 2021.
5. Chiasson J. M., Smith W. J., Jodlowski T. Z. et al. Impact of a rapid blood culture diagnostic panel on time to optimal antimicrobial therapy at a veterans affairs medical center // J Pharm Pract. – 2022. – Vol. 35, № 5. – P. 722–729. doi: 10.1177/08971900211000686.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献